Abiopharma

🔍 LIDDELL KIM C (Executive)

Company: Lake Shore Bancorp, Inc. /MD/ (LSBK)

Report Date: 2026-04-23

Detailed Transactions and Holdings:

• Sold 631 shares of Common Stock at $15.85 per share (Direct)
  Date: 2026-04-23 | Code: F | equity_swap_involved: false | shares_owned_after: 70,367.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-23 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 10,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-23 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 41,661.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-23 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 1,949.00 | Footnotes: F5

Footnotes:

• F1: The reporting person elected to pay for a tax liability by withholding securities incident to the vesting of a security (restricted stock) based on a market price of $15.85.
• F2: Includes 6,363 remaining shares of unvested restricted stock that were granted on March 12, 2025 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
• F3: Includes 3,499 remaining shares of unvested restricted stock that were granted on April 23, 2024 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant. 1,748 shares vested on April 23, 2026.
• F4: Includes 6,285 shares of unvested restricted stock that were granted on March 18, 2026 and vest in four equal annual installments beginning on the first anniversary of the grant.
• F5: These shares were acquired pursuant to an Employee Stock Ownership Plan Allocation.